Want to join the conversation?
$ITW raised its 2016 full-year earnings outlook range by $0.10 to $5.50 to $5.70. $ITW however cut its full-year organic growth forecast to 1 to 2% from its prior forecast of 1 to 3%, citing difficult market conditions faced by the company's welding segment.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.